Pan PY - Search Results

1

Tocilizumab overcomes chemotherapy resistance in mesenchymal stem-like breast cancer by negating autocrine IL-1A induction of IL-6.

Chung AW, Kozielski AJ, Qian W, Zhou J, Anselme AC, Chan AA, Pan PY, Lee DJ, Chang JC. Chung AW, et al. Among authors: pan py. NPJ Breast Cancer. 2022 Mar 8;8(1):30. doi: 10.1038/s41523-021-00371-0. NPJ Breast Cancer. 2022. PMID: 35260569 Free PMC article.

2

A phase 1/2 clinical trial of the nitric oxide synthase inhibitor L-NMMA and taxane for treating chemoresistant triple-negative breast cancer.

Chung AW, Anand K, Anselme AC, Chan AA, Gupta N, Venta LA, Schwartz MR, Qian W, Xu Y, Zhang L, Kuhn J, Patel T, Rodriguez AA, Belcheva A, Darcourt J, Ensor J, Bernicker E, Pan PY, Chen SH, Lee DJ, Niravath PA, Chang JC. Chung AW, et al. Among authors: pan py. Sci Transl Med. 2021 Dec 15;13(624):eabj5070. doi: 10.1126/scitranslmed.abj5070. Epub 2021 Dec 15. Sci Transl Med. 2021. PMID: 34910551 Clinical Trial.

3

A Phase 2 Study of In Situ Oncolytic Virus Therapy and Stereotactic Body Radiation Therapy Followed by Pembrolizumab in Metastatic Non-Small Cell Lung Cancer.

Guan J, Sun K, Guerrero CA, Zheng J, Xu Y, Mathur S, Teh BS, Farach A, Zhang J, Butler E, Pan PY, Zsigmond E, Mei Z, Mejia J, Chen SH, Chang JC, Bernicker EH. Guan J, et al. Among authors: pan py. Int J Radiat Oncol Biol Phys. 2024 Apr 1;118(5):1531-1540. doi: 10.1016/j.ijrobp.2023.08.044. Epub 2023 Aug 24. Int J Radiat Oncol Biol Phys. 2024. PMID: 37625523 Clinical Trial.

4

LILRB3 Modulates Acute Myeloid Leukemia Progression and Acts as an Effective Target for CAR T-cell Therapy.

Mai S, Hodges A, Chen HM, Zhang J, Wang YL, Liu Y, Nakatsu F, Wang X, Fang J, Xu Y, Davidov V, Kang K, Pingali SR, Ganguly S, Suzuki M, Konopleva M, Prinzing B, Zu Y, Gottschalk S, Lu Y, Chen SH, Pan PY. Mai S, et al. Among authors: pan py. Cancer Res. 2023 Dec 15;83(24):4047-4062. doi: 10.1158/0008-5472.CAN-22-2483. Cancer Res. 2023. PMID: 38098451

5

Analyzing One Cell at a TIME: Analysis of Myeloid Cell Contributions in the Tumor Immune Microenvironment.

Davidov V, Jensen G, Mai S, Chen SH, Pan PY. Davidov V, et al. Among authors: pan py. Front Immunol. 2020 Sep 2;11:1842. doi: 10.3389/fimmu.2020.01842. eCollection 2020. Front Immunol. 2020. PMID: 32983100 Free PMC article. Review.

6

Corrigendum: Analyzing One Cell at a TIME: Analysis of Myeloid Cell Contributions in the Tumor Immune Microenvironment.

Davidov V, Jensen G, Mai S, Chen SH, Pan PY. Davidov V, et al. Among authors: pan py. Front Immunol. 2021 Feb 1;11:645213. doi: 10.3389/fimmu.2020.645213. eCollection 2020. Front Immunol. 2021. PMID: 33597955 Free PMC article.

7

Dedifferentiation-mediated stem cell niche maintenance in early-stage ductal carcinoma in situ progression: insights from a multiscale modeling study.

Butner JD, Dogra P, Chung C, Ruiz-Ramírez J, Nizzero S, Plodinec M, Li X, Pan PY, Chen SH, Cristini V, Ozpolat B, Calin GA, Wang Z. Butner JD, et al. Among authors: pan py. Cell Death Dis. 2022 May 21;13(5):485. doi: 10.1038/s41419-022-04939-x. Cell Death Dis. 2022. PMID: 35597788 Free PMC article.

8

World Trade Center dust exposure promotes cancer in PTEN-deficient mouse prostates.

Wang L, Xu Y, Zhang L, Kang K, Kobryn A, Portman K, Gordon RE, Pan PY, Taioli E, Aaronson SA, Chen SH, Mulholland DJ. Wang L, et al. Among authors: pan py. Cancer Res Commun. 2022;2(6):518-532. doi: 10.1158/2767-9764.crc-21-0111. Cancer Res Commun. 2022. PMID: 35911788 Free PMC article.

9

Nutrient supplements from selected botanicals mediated immune modulation of the tumor microenvironment and antitumor mechanism.

Chen HM, Sun L, Pan PY, Wang LH, Chen SH. Chen HM, et al. Among authors: pan py. Cancer Immunol Immunother. 2021 Dec;70(12):3435-3449. doi: 10.1007/s00262-021-02927-2. Epub 2021 Apr 20. Cancer Immunol Immunother. 2021. PMID: 33877384 Free PMC article.

10

Patients with Lung Cancer of Different Racial Backgrounds Harbor Distinct Immune Cell Profiles.

Xu Y, Zhang L, Thaiparambil J, Mai S, Perera DN, Zhang J, Pan PY, Coarfa C, Ramos K, Chen SH, El-Zein R. Xu Y, et al. Among authors: pan py. Cancer Res Commun. 2022 Aug 29;2(8):884-893. doi: 10.1158/2767-9764.CRC-22-0057. eCollection 2022 Aug. Cancer Res Commun. 2022. PMID: 36923308 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

109 results

Search Page